One of the nation's top breast surgeons, Marc E. Boisvert, MD, FACS, has trained many other breast surgeons in practice throughout the world and has been named one of the best doctors in the region and nation over the past several years.
Dr. Boisvert is the site director of the MedStar Breast Health Program at MedStar Washington Hospital Center. Since 2000, he has been director of the Georgetown University Hospital Breast Oncology Fellowship Program, the only breast fellowship program in the Washington, D.C. metro area. This one-year program, conducted after completion of surgical residency, allows young surgeons to gain additional specialty training. Additionally, Dr. Boisvert is chief of the division of Breast Surgery and a clinical associate professor of surgery at Georgetown University School of Medicine. On his watch, intraoperative radiation therapy for breast cancer treatment started at the Hospital Center, where he has been the medical director since 1994. The Breast Health Program is accredited by the National Accreditation Program for Breast Centers. He has practiced at MedStar Washington Hospital Center since 1986.
Dr. Boisvert frequently performs low re-excision rate partial mastectomy with oncoplastic closure provided by experienced plastic surgeons, skin and nipple-sparing mastectomy, sentinel node biopsy, axillary dissection, and intraoperative radiation therapy.
At Washington Cancer Institute at MedStar Washington Hospital Center, breast care focuses on the entire patient and is provided by a highly specialized team. We provide care through an interdisciplinary tumor board, a broad panel of experts in all areas of breast cancer care, including nurse navigators, nurse practitioners, and access to the latest technology and treatments through clinical trials.
The hospital's ongoing clinical trials allow selected patients with initially positive lymph nodes to forego axillary dissection after neoadjuvant chemotherapy. This is something very new and breast surgeons here are on the verge of using radioactive seed localization instead of wire localization for nonpalpable breast tumors. These seeds can be placed several days before a surgical procedure, unlike wires which need to be placed the same day. This advance shortens the time needed to access the operating room.